17 May 2016 - Communicable Disease Control Branch
Thirty percent of Neisseria gonorrhoeae strains from South Australia in the first quarter of 2016 had reduced susceptibility to azithromycin, compared to 0.9% to 3.9% for other states. All strains remained fully susceptible to ceftriaxone.
Azithromycin is not a first line drug for treatment of gonorrhoea; it should only be used for patients allergic to cephalosporins or with severe penicillin allergy i.e. anaphylaxis/angioedema/urticaria.
24 March 2016 - Communicable Disease Control Branch
Tuberculosis (TB) is uncommon in Australia but should be readily diagnosable and treatable, although the emergence of drug resistance poses a threat. Migrants from high TB burden comprise 90% of cases in South Australia. A study conducted here between 2010 and 2014 showed greater than 50% of TB diagnoses exceeded 1 month from initial presentation and a key reason was failure to consider TB. This information is intended to provide guidance on the early detection of TB.
When to consider TB in the risk groups
> cough or persistent chest infection for more than 2 weeks ±
> other respiratory symptoms - dyspnoea, chest pain, haemoptysis and/or
> constitutional symptoms - loss of appetite, weight loss, fever, night sweats, fatigue